1.7(top 50%)
impact factor
8.5K(top 2%)
papers
83.7K(top 5%)
citations
100(top 5%)
h-index
1.8(top 50%)
impact factor
9.3K
all documents
89.0K
doc citations
143(top 5%)
g-index

Top Articles

#TitleJournalYearCitations
1A new histological grading system to assess response of breast cancers to primary chemotherapy: prognostic significance and survivalBreast2003738
2Clinical implications of the intrinsic molecular subtypes of breast cancerBreast2015735
3Current and future burden of breast cancer: Global statistics for 2020 and 2040Breast2022600
4Proliferation markers and survival in early breast cancer: A systematic review and meta-analysis of 85 studies in 32,825 patientsBreast2008353
5Abandoning sentinel lymph node biopsy in early breast cancer? A new trial in progress at the European Institute of Oncology of Milan (SOUND: entinel node vs bservation after axillary ltraSou )Breast2012353
6Quality of life and patient satisfaction in breast cancer patients after immediate breast reconstruction: a prospective studyBreast2005320
71st International consensus guidelines for advanced breast cancer (ABC 1)Breast2012291
8ESO-ESMO 2nd international consensus guidelines for advanced breast cancer (ABC2)Breast2014269
9Obesity and breast cancer: a review of the literatureBreast2004255
10Long-term oncological results of breast conservative treatment with oncoplastic surgeryBreast2007251
11Comparison between breast volume measurement using 3D surface imaging and classical techniquesBreast2007244
12Extracellular matrix components in breast cancer progression and metastasisBreast2013221
13Categorizing breast mammographic density: intra- and interobserver reproducibility of BI-RADS density categoriesBreast2005210
14Improving the therapeutic index of anthracycline chemotherapy: Focus on liposomal doxorubicin (Myocet™)Breast2009204
15ESO-ESMO 3rd international consensus guidelines for breast cancer in young women (BCY3)Breast2017203
16Characteristics and outcomes according to molecular subtypes of breast cancer as classified by a panel of four biomarkers using immunohistochemistryBreast2012201
17The effect of exercise on fatigue and physical functioning in breast cancer patients during and after treatment and at 6 months follow-up: A meta-analysisBreast2017196
18Higher efficacy of letrozole in combination with trastuzumab compared to letrozole monotherapy as first-line treatment in patients with HER2-positive, hormone-receptor-positive metastatic breast cancer – Results of the eLEcTRA trialBreast2012195
19The genomic landscape of breast cancer and its interaction with host immunityBreast2016194
20Treatment of HER2-positive breast cancerBreast2014191
21Cyclin D1 and breast cancerBreast2006188
22Recommendations for triage, prioritization and treatment of breast cancer patients during the COVID-19 pandemicBreast2020188
23The effects of adjuvant chemotherapy on cognition in women with breast cancer—preliminary results of an observational longitudinal studyBreast2005187
24Review of radiation dose estimates in digital breast tomosynthesis relative to those in two-view full-field digital mammographyBreast2015186
25Trends and predictions to 2020 in breast cancer mortality in EuropeBreast2017186
26Self-reported arm-lymphedema and functional impairment after breast cancer treatment – A nationwide study of prevalence and associated factorsBreast2010185
27Inflammation and cancer: Breast cancer as a prototypeBreast2007181
28Nipple-sparing and skin-sparing mastectomy: Review of aims, oncological safety and contraindicationsBreast2017181
29The impact of age and clinical factors on quality of life in early breast cancer: An analysis of 2208 women recruited to the UK START Trial (Standardisation of Breast Radiotherapy Trial)Breast2007172
30Management of triple negative breast cancerBreast2010171
313rd ESO–ESMO international consensus guidelines for Advanced Breast Cancer (ABC 3)Breast2017171
32Global analysis of advanced/metastatic breast cancer: Decade report (2005–2015)Breast2018167
33Overexpression of Bmi-1 oncoprotein correlates with axillary lymph node metastases in invasive ductal breast cancerBreast2004165
34Early prediction of pathologic response to neoadjuvant therapy in breast cancer: Systematic review of the accuracy of MRIBreast2012165
35Sensitivity of MRI versus conventional screening in the diagnosis of BRCA-associated breast cancer in a national prospective seriesBreast2007164
36p53 in breast cancer subtypes and new insights into response to chemotherapyBreast2013164
37Overview of the evidence on digital breast tomosynthesis in breast cancer detectionBreast2013163
38Current and future role of neoadjuvant therapy for breast cancerBreast2014162
39Overview of radiomics in breast cancer diagnosis and prognosticationBreast2020161
40Incidence and risk factors of lymphedema after breast cancer treatment: 10 years of follow-upBreast2017160
41Cardiotoxicity associated with trastuzumab (Herceptin) therapy in the treatment of metastatic breast cancerBreast2004155
42Breast cancer management in low resource countries (LRCs): Consensus statement from the Breast Health Global InitiativeBreast2011154
43Evaluation of sentinel node biopsy by combined fluorescent and dye method and lymph flow for breast cancerBreast2010151
44Epirubicin: Is it like doxorubicin in breast cancer? A clinical reviewBreast2012151
45The severity, outcome and challenges of breast cancer in NigeriaBreast2006149
46Turning subjective into objective: The BCCT.core software for evaluation of cosmetic results in breast cancer conservative treatmentBreast2007149
47The Central-European SentiMag study: Sentinel lymph node biopsy with superparamagnetic iron oxide (SPIO) vs. radioisotopeBreast2014147
48Factors affecting post-operative complications following skin sparing mastectomy with immediate breast reconstructionBreast2011145
49The impact of exercise during adjuvant radiotherapy for breast cancer on fatigue and quality of life: A systematic review and meta-analysisBreast2017145
50Aromatase inhibitor-associated arthralgia syndromeBreast2007143